We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are four stocks with buy rank and strong value characteristics for investors to consider today, April 14th:
Louisiana-Pacific Corporation (LPX - Free Report) : This company that manufactures building materials and engineered wood products has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 58.7% over the last 60 days.
Textainer Group Holdings Limited : This company that purchases, owns, manages, leases, and disposes a fleet of intermodal containers has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 74.7% over the last 60 days.
Textainer Group Holdings Limited Price and Consensus
Mid Penn Bancorp, Inc. (MPB - Free Report) : This bank holding company for Mid Penn Bank has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 13.9% over the last 60 days.
Oasis Midstream Partners LP : This company that owns, develops, operates and acquires a diversified portfolio of midstream assets has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 12.2% over the last 60 days.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Top Ranked Value Stocks to Buy for April 14th
Here are four stocks with buy rank and strong value characteristics for investors to consider today, April 14th:
Louisiana-Pacific Corporation (LPX - Free Report) : This company that manufactures building materials and engineered wood products has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 58.7% over the last 60 days.
Louisiana-Pacific Corporation Price and Consensus
Louisiana-Pacific Corporation price-consensus-chart | Louisiana-Pacific Corporation Quote
Louisiana-Pacific has a price-to-earnings ratio (P/E) of 8.66, compared with 16.90 for the industry. The company possesses a Value Score of B.
Louisiana-Pacific Corporation PE Ratio (TTM)
Louisiana-Pacific Corporation pe-ratio-ttm | Louisiana-Pacific Corporation Quote
Textainer Group Holdings Limited : This company that purchases, owns, manages, leases, and disposes a fleet of intermodal containers has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 74.7% over the last 60 days.
Textainer Group Holdings Limited Price and Consensus
Textainer Group Holdings Limited price-consensus-chart | Textainer Group Holdings Limited Quote
Textainer Group has a price-to-earnings ratio (P/E) of 7.48, compared with 34.60 for the industry. The company possesses a Value Score of A.
Textainer Group Holdings Limited PE Ratio (TTM)
Textainer Group Holdings Limited pe-ratio-ttm | Textainer Group Holdings Limited Quote
Mid Penn Bancorp, Inc. (MPB - Free Report) : This bank holding company for Mid Penn Bank has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 13.9% over the last 60 days.
Mid Penn Bancorp, Inc. Price and Consensus
Mid Penn Bancorp, Inc. price-consensus-chart | Mid Penn Bancorp, Inc. Quote
Mid Penn Bancorp has a price-to-earnings ratio (P/E) of 7.79, compared with 13.50 for the industry. The company possesses a Value Score of B.
Mid Penn Bancorp, Inc. PE Ratio (TTM)
Mid Penn Bancorp, Inc. pe-ratio-ttm | Mid Penn Bancorp, Inc. Quote
Oasis Midstream Partners LP : This company that owns, develops, operates and acquires a diversified portfolio of midstream assets has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 12.2% over the last 60 days.
Oasis Midstream Partners LP Price and Consensus
Oasis Midstream Partners LP price-consensus-chart | Oasis Midstream Partners LP Quote
Oasis Midstream Partners has a price-to-earnings ratio (P/E) of 7.29, compared with 9.40 for the industry. The company possesses a Value Score of B.
Oasis Midstream Partners LP PE Ratio (TTM)
Oasis Midstream Partners LP pe-ratio-ttm | Oasis Midstream Partners LP Quote
See the full list of top ranked stocks here.
Learn more about the Value score and how it is calculated here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>